FOREST SAP PATCH- topical starch poultice Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

forest sap patch- topical starch poultice

e-house korea holdings international - starch, corn (unii: o8232ny3sj) (starch, corn - unii:o8232ny3sj) - starch, corn 3.16 g in 4 g

WARM SAP PATCH- topical starch poultice Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

warm sap patch- topical starch poultice

e-house korea holdings international - starch, corn (unii: o8232ny3sj) (starch, corn - unii:o8232ny3sj) - starch, corn 3.16 g in 4 g

MEXSANA MEDICATED- starch, corn powder Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

mexsana medicated- starch, corn powder

bayer healthcare llc - starch, corn (unii: o8232ny3sj) (starch, corn - unii:o8232ny3sj) - starch, corn 837 mg in 1 g - skin protectant temporarily protects and helps relieve minor skin irritation

VOLUVEN 6% hydroxyethyl starch 130/0.4 500 mL solution for intravenous infusion bag Australien - Englisch - Department of Health (Therapeutic Goods Administration)

voluven 6% hydroxyethyl starch 130/0.4 500 ml solution for intravenous infusion bag

fresenius kabi australia pty ltd - hydroxyethyl starch 130/0.4, quantity: 60 g/l - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; sodium hydroxide - treatment of hypovolaemia due to acute blood loss when crystalloids alone are not considered sufficient. the use of voluven is not a substitute for the appropriate use of packed red blood cells or fresh frozen plasma.

VOLUVEN 6% hydroxyethyl starch 130/0.4 250 mL solution for intravenous infusion bag Australien - Englisch - Department of Health (Therapeutic Goods Administration)

voluven 6% hydroxyethyl starch 130/0.4 250 ml solution for intravenous infusion bag

fresenius kabi australia pty ltd - hydroxyethyl starch 130/0.4, quantity: 60 g/l - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid; sodium chloride - treatment of hypovolaemia due to acute blood loss when crystalloids alone are not considered sufficient. the use of voluven is not a substitute for the appropriate use of packed red blood cells or fresh frozen plasma.

VOLUVEN 6% hydroxyethyl starch 130/0.4 500 mL solution for intravenous infusion bottle Australien - Englisch - Department of Health (Therapeutic Goods Administration)

voluven 6% hydroxyethyl starch 130/0.4 500 ml solution for intravenous infusion bottle

fresenius kabi australia pty ltd - hydroxyethyl starch 130/0.4, quantity: 60 g/l - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; sodium hydroxide - treatment of hypovolaemia due to acute blood loss when crystalloids alone are not considered sufficient. the use of voluven is not a substitute for the appropriate use of packed red blood cells or fresh frozen plasma.

VOLUVEN 6% hydroxyethyl starch 130/0.4 250 mL solution for intravenous infusion bottle Australien - Englisch - Department of Health (Therapeutic Goods Administration)

voluven 6% hydroxyethyl starch 130/0.4 250 ml solution for intravenous infusion bottle

fresenius kabi australia pty ltd - hydroxyethyl starch 130/0.4, quantity: 60 g/l - injection, solution - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid; sodium chloride - treatment of hypovolaemia due to acute blood loss when crystalloids alone are not considered sufficient. the use of voluven is not a substitute for the appropriate use of packed red blood cells or fresh frozen plasma.

FOREST SAP PATCH- topical starch poultice Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

forest sap patch- topical starch poultice

e-house korea holdings international - starch, corn (unii: o8232ny3sj) (starch, corn - unii:o8232ny3sj) - starch, corn 3.16 g in 4 g

Byannli (previously Paliperidone Janssen-Cilag International) Europäische Union - Englisch - EMA (European Medicines Agency)

byannli (previously paliperidone janssen-cilag international)

janssen-cilag international n.v.   - paliperidone palmitate - schizophrenia - psycholeptics - byannli (previously paliperidone janssen-cilag international) a 6 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly or 3 monthly paliperidone palmitate injectable products (see section 5.1).